- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Price disconnect
Taiwanese Pharmaceuticals & Biotech Price disconnect
Results
6
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
6 companies
TTY Biopharm
Market Cap: NT$18.8b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.
4105
NT$75.80
7D
-0.5%
1Y
-1.7%
Standard Chemical & Pharmaceutical
Market Cap: NT$11.4b
Manufactures and sells pharmaceutical products in Taiwan and internationally.
1720
NT$57.60
7D
2.7%
1Y
10.4%
Cenra
Market Cap: NT$4.8b
Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.
3716
NT$32.95
7D
-1.2%
1Y
-1.9%
TSH Biopharm
Market Cap: NT$1.9b
Develops and markets pharmaceutical products in Taiwan.
8432
NT$48.80
7D
-3.0%
1Y
3.7%
Taiwan Advance Bio-Pharmaceutical
Market Cap: NT$821.7m
Operates in the biotechnology industry in China, Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally.
4186
NT$8.80
7D
-7.4%
1Y
-16.2%
Bioray Biotech
Market Cap: NT$547.3m
Engages in the research, development, production, and sells health foods, immune cell products, and precision testing services in Taiwan.
7561
NT$17.85
7D
-12.7%
1Y
-26.8%